INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
02/03/2024
Voltar para busca
Dado oficial do USPTO
DAIKYO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
02/03/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
10, 17, 20, 21
Data de depósito
03/04/2020
Data de registro
07/09/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/09/2021
Última transação
27/06/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
03
Localização do titular
JP
Examinador
BROWNE, LUCY E
Unidade examinadora
N70
Localização atual
TMO LAW OFFICE 125
Descrição da marca
The mark consists of the following: the blue wording "DAIKYO".
Titulares e representantes
Titulares
DAIKYO SEIKO, LTD.
Representantes
N. Alexander Nolte NOLTE LACKENBACH SIEGEL
Classificação técnica
Classes Nice
Classe 10Classe 17Classe 20Classe 21
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 10
Medical apparatusinfusion plugs for use with injection devices for administering drugs; rubber stoppers for use with medical apparatusinfusion devices for administering drugs; rubber stoppers being structural parts of medical sample vials; rubber closures being structural components of drug delivery devicesmedical infusion bags sold empty; rubber closures being structural components of drug delivery devicesmedical infusion bottles sold empty; rubber stoppers being structural parts of medical instruments for use with medical containers for medical aqueous infusion purposes; medical syringes; injection syringes for medical purposes; structural fitted parts for medical syringes in the nature of pistons used to help dispense contents upon pressure; structural fitted parts for medical syringes in the nature of plungers used to help dispense contents upon pressure; structural fitted parts for medical syringes in the nature of finger grip adapters for use with flanges of syringe barrels of medical syringes; rubber nozzle caps being structural parts of medical syringes; medical instrumentsinfusion devices for administering medicine; medical plastic sealing caps being structural parts of medicine containers specially adapted for medical instruments for preventing the removal of rubber closures that seal mouths of medicine containers; medical rubber sealing caps being structural parts of medicine containers specially adapted for medical instruments for preventing the removal of rubber closures that seal mouths of medicine containers; medical plastic sealing caps with built-in rubber closures for sealing mouths of medicine containers especially adapted for medical instruments; medical rubber sealing caps with built-in rubber closures for sealing mouths of medicine containers especially adapted for medical instruments; medical rubber * nozzle * caps being a structural part of injection syringes; rubber stoppers and closures being structural parts of medical instruments for use with medical containers for medical aqueous infusion purposes; medical o-rings being a structural part of nebulizers for administering medication in the form of a mist inhaled into the lungs for treatment of asthma and respiratory diseases; medical tubing connectors being structural parts of medical infusion and intravenous feeding tubes; medical diagnostic and analytical apparatusmicroplates for testing blood sugar levelscancer cells and DNA; containers for medical solutionsinjection solution cartridges for medical syringe pens sold empty; rubber stoppers being structural parts of containers for medical solutionsinjection solution cartridges for medical syringe pens; syringe barrels and needles for medical useas parts of syringes for medical purposes and for injections; plastic caps being structural parts of medical injection syringes; rubber caps being structural parts of medical injection syringes; injection solution containerssold emptywhich can be loaded and filled in medical syringe barrels in the nature of medical injection syringes and medical cartridge syringes; * medical * rubber closures being structural parts of medical sample vials; plastic stoppers for use with drug delivery devicesbeing structural parts ofmedical infusion bags; rubber stoppers for use with drug delivery devicesbeing structural parts ofmedical infusion bags; plastic stoppers being structural parts of drug delivery devicesmedical infusion bottles; * medical * rubber stoppers being structural parts of drug delivery devicesmedical infusion bottles; * medical * rubber closures being structural parts of medical containers used to store raw pharmaceutical materials in the nature of syringes and chemical intermediates; rubber closures specially adapted for medical containers that are used for storing raw pharmaceutical materials in the nature of syringeschemical intermediatesfinal products for medicinal purposes; rubber closures and stoppers specially adapted for medical blood collecting tubes; plastic nozzle caps being structural parts of syringes that have detachable needles; rubber nozzle caps being structural parts of syringes that have detachable needles; plastic sealing caps being structural parts of medicinal vial containers for preventing the removal of rubber closures that seal mouths of medicinal vial containers; medical plastic sealing caps being structural parts of medicinal vial containers with built-in rubber closures for sealing mouths of medicinal vial containers
Classe 17
O-rings of rubberrubber seals being sealing rings for use as connection seals; packing materials made of rubber; industrial packaging containers of rubber; rubber stoppers for medicine containers; rubber lids and caps; rubberraw or semi-worked; rubber bottle stoppers; rubber sealing plugs for use with medical diagnostic and analytical apparatusmedical microplates for testing blood sugar levelscancer cells and DNA; rubber bottle stoppers for containing medicinal solutions in bottles
Classe 20
Packaging containers of plastic for use in storing medicines; packaging containers of plastic; plastic sealing caps * as accessories for rubber closures * for preventing the removal of rubber closures that seal mouths of plastic freezing and drying containers; plastic sealing caps * as accessories for rubber closures * for preventing the removal of rubber closures that seal mouths of plastic packaging containers; plastic sealing caps with built-in rubber seal for sealing mouths of plastic freezing and drying containers; plastic sealing caps with built-in rubber seal for sealing mouths of plastic packaging containers; plastic lids and caps for plastic packaging containers; plastic safety caps for drug and medicine containers; rubber sealing closures as integral components of plastic lids for plastic containers for the storage of medicines; rubber sealing closures as integral components of plastic lids for glass vial-shaped medication containers for the storage of medicines; packaging containers of plastic for the storage of medicines; plastic medication containers for commercial use; packaging containers of plastic for the storage of medicines prior to administration; packaging containers of plastic for storing infusion kits; packaging containers of plastic for intravenous solutions; packaging containers of plastic for parenteral medical solutions; packaging containers of plastic for medical instruments; medical packaging plastic containers for use in storing parenteral drugs
Classe 21
Vial-shaped plastic bottlessold empty; plastic bottles for medical usesold empty; plastic vials for medicinesold empty
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
26/02/2024
NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
01/08/2023
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
19/07/2023
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
19/07/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
26/06/2023
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
26/06/2023
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
25/06/2023
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
17/06/2023
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
16/06/2023
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
27/03/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/03/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
15/02/2022
FIMP
FINAL DISPOSITION PROCESSED
15/02/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/12/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
07/09/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/06/2021
PUBO
PUBLISHED FOR OPPOSITION
22/06/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/06/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/05/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
13/05/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
13/05/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
13/05/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
13/05/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/03/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/03/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/03/2021
ATRV
ATTORNEY REVIEW COMPLETED
14/01/2021
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
17/12/2020
RFNT
REFUSAL PROCESSED BY IB
21/11/2020
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
01/11/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
30/10/2020
RFRR
REFUSAL PROCESSED BY MPU
30/10/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/10/2020
CNRT
NON-FINAL ACTION WRITTEN
06/10/2020
MAFR
APPLICATION FILING RECEIPT MAILED
01/09/2020
DOCK
ASSIGNED TO EXAMINER
28/08/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/08/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
27/08/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DAIKYO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.